Keyphrases
Adult Patients
20%
Amiloride
16%
Asthma
37%
Asthma children
21%
Asthma Control
27%
Atypical Asthma
8%
Azithromycin
16%
Barcelona
16%
Burkholderia Cepacia Complex
16%
Cardiopulmonary Parameters
6%
Cotrimoxazole
16%
Cystic Fibrosis
86%
Electrical Properties
16%
Eradication Therapy
8%
European Respiratory Society
32%
Exocrine Pancreatic Function
16%
Fecal Elastase
10%
Forced Expiratory Volume in 1 Second (FEV1)
8%
Function Properties
16%
HCl Solution
9%
Hepatic Function
16%
Ileal Atresia
10%
Inhalation
16%
Inhalation Technique
10%
Inhaled Corticosteroids
18%
Inhaled Medications
8%
Intensive Care Medicine
8%
International Congresses
16%
Intestinal Fat Absorption
16%
Intravenous Antibiotics
8%
Ivacaftor
16%
Jejunal Atresia
10%
Jejunoileal Atresia
16%
Long-term Safety
16%
Maintenance Treatment
8%
Medicinal Treatment
16%
Oral Medication
8%
Outpatient Visits
16%
Partial Recovery
16%
Pediatric
32%
Pediatric Pulmonologists
16%
Pharmacy
16%
Pilocarpine
16%
Remote Monitoring Program
7%
Renal Function
16%
Sweat Test
18%
Target Attainment
16%
Tobramycin
32%
Treatment Adherence
10%
Weight Gain
10%
Medicine and Dentistry
6 Diazo 5 Oxonorleucine
16%
Amiloride
16%
Antibiotics
18%
Asthma
49%
Asthma in Children
32%
Atresia
16%
Azithromycin
16%
Biological Marker
18%
Burkholderia Cepacia Complex
16%
Chronic Respiratory Tract Disease
16%
Cohort Effect
5%
Colistimethate
16%
Congenital Pulmonary Airway Malformation
16%
Critical Appraisal
8%
Cystic Fibrosis
63%
Diagnosis
5%
Drug Dose Regimen
5%
Drug Megadose
5%
Drug Therapy
38%
Dry Powder Inhaler
16%
Elastase
10%
Eradication Therapy
16%
Health Care
9%
Immunology
5%
Intensive Care
5%
Ivacaftor
16%
Kidney Function
18%
Leukotriene Receptor Blocking Agent
5%
Lipid Absorption
16%
Liver Function
16%
Maintenance Therapy
12%
Neonatology
5%
Outpatient
16%
Pancreas Function
16%
Pancreatic Insufficiency
5%
Patient with Cystic Fibrosis
49%
Pediatrics
48%
Physical Activity
16%
Pseudomonas aeruginosa
17%
QTc Interval
10%
Remote Sensing
16%
Respiratory Physiology
5%
Respiratory Tract Infection
5%
Spirometry
7%
Sympathomimetic Drug
10%
Symptom
15%
Tobramycin
35%
Transplantation
16%
Treatment of Asthma
5%
Trimethoprim/Sulfamethoxazole
16%
Pharmacology, Toxicology and Pharmaceutical Science
Adrenergic Receptor Stimulating Agent
16%
Adverse Event
6%
Amiloride
16%
Antibiotic Agent
25%
Asthma
48%
Azithromycin
16%
Biological Marker
16%
Budesonide
5%
Burkholderia Cepacia Complex
16%
Ciclesonide
16%
Colistimethate
16%
Cotrimoxazole
16%
Cystic Fibrosis
100%
Dry Powder Inhaler
16%
Elastase
10%
Fluticasone
5%
Ivacaftor
16%
Leukotriene Receptor Blocking Agent
8%
Pancreatic Insufficiency
5%
Pharmacokinetics
16%
Pilocarpine
16%
Pseudomonas aeruginosa
17%
Side Effect
6%
Symptom
14%
Tobramycin
52%
